{"entity":{"type":"insider","cik":"0001815308","url":"/insider/0001815308","json_url":"/insider/0001815308.json","name":"Piekos Brian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2021-05-18","last":"2026-05-26","span_basis":"filed_date"},"name_variants":[{"name":"Piekos Brian","source":"filing","n_filings":5,"first_seen":"2021-05-18","last_seen":"2026-05-26"}],"transactions":[{"id":5996643,"accession":"0001815308-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001815308-26-000004","line_url":"/filing/0001815308-26-000004#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001815308","owner_name":"Piekos Brian","owner_display_name":"Piekos Brian","owner_url":"/insider/0001815308","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1489.0,"shares_display":"1,489","price_per_share":26.7844,"price_display":"26.78","price_state":"stated","total_value":39881.9716,"total_display":"39,881.97","total_whole":"39,882","shares_owned_after":21661.0,"shares_owned_after_display":"21,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-22","filed_date":"2026-05-26","scope":"insider"},{"id":6047122,"accession":"0001815308-26-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001815308-26-000003","line_url":"/filing/0001815308-26-000003#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001815308","owner_name":"Piekos Brian","owner_display_name":"Piekos Brian","owner_url":"/insider/0001815308","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1862.0,"shares_display":"1,862","price_per_share":20.2163,"price_display":"20.22","price_state":"stated","total_value":37642.7506,"total_display":"37,642.75","total_whole":"37,643","shares_owned_after":18150.0,"shares_owned_after_display":"18,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-17","filed_date":"2026-04-20","scope":"insider"},{"id":5935837,"accession":"0001815308-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001815308-26-000002","line_url":"/filing/0001815308-26-000002#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001815308","owner_name":"Piekos Brian","owner_display_name":"Piekos Brian","owner_url":"/insider/0001815308","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1767.0,"shares_display":"1,767","price_per_share":15.5668,"price_display":"15.57","price_state":"stated","total_value":27506.5356,"total_display":"27,506.54","total_whole":"27,507","shares_owned_after":13762.0,"shares_owned_after_display":"13,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-24","scope":"insider"},{"id":4155379,"accession":"0001815308-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001815308-25-000004","line_url":"/filing/0001815308-25-000004#line-2","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001815308","owner_name":"Piekos Brian","owner_display_name":"Piekos Brian","owner_url":"/insider/0001815308","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4471.0,"shares_display":"4,471","price_per_share":13.451,"price_display":"13.45","price_state":"stated","total_value":60139.421,"total_display":"60,139.42","total_whole":"60,139","shares_owned_after":10529.0,"shares_owned_after_display":"10,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-26","scope":"insider"},{"id":5363783,"accession":"0000899243-21-019763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-019763","line_url":"/filing/0000899243-21-019763#line-1","is_derivative":false,"issuer_cik":"0001815308","issuer_name":"Gemini Therapeutics, Inc. /DE","issuer_ticker":"GMTX","issuer_name_source":null,"issuer_url":"/issuer/0001815308","owner_cik":"0001815308","owner_name":"Piekos Brian","owner_display_name":"Piekos Brian","owner_url":"/insider/0001815308","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7655.0,"shares_display":"7,655","price_per_share":9.462,"price_display":"9.46","price_state":"stated","total_value":72431.61,"total_display":"72,431.61","total_whole":"72,432","shares_owned_after":7655.0,"shares_owned_after_display":"7,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001348911","name":"KalVista Pharmaceuticals, Inc.","url":"/issuer/0001348911","role":"Officer (Chief Financial Officer)","n_filings":4,"first_seen":"2025-11-26","last_seen":"2026-05-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001816736","name":"Gemini Therapeutics, Inc. /DE","url":"/issuer/0001816736","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2021-05-18","last_seen":"2021-05-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001815308","retrieved_at":"2026-08-24T06:46:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}